Qube Research & Technologies Ltd

Position in CRDF — Cardiff Oncology, Inc.

CIK 1729829 LONDON, X0

Position in CRDF

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$163,215

+$63,771 QoQ

Shares Held

125,550

+237.1% QoQ

Ownership

0.161%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 104 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. CRDF ranks #140 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$163,215	125,550	+237.1%	Shares	Sole	2026-08-14
2024-09-30	$99,444	37,245	-8.4%	Shares	Sole	2024-11-14
2024-06-30	$90,274	40,664	-68.1%	Shares	Sole	2024-08-14
2024-03-31	$679,691	127,283	+244675.0%	Shares	Sole	2024-05-14
2023-12-31	$76	52	0.0%	Shares	Sole	2024-02-13
2023-09-30	$72	52	-99.8%	Shares	Sole	2023-11-13
2022-09-30	$46,193	29,996	-9.2%	Shares	Sole	2022-11-14
2022-06-30	$72,683	33,038	+115.4%	Shares	Sole	2022-08-15
2021-06-30	$101,977	15,335	-74.7%	Shares	Sole	2021-08-13
2021-03-31	$561,591	60,647	-37.1%	Shares	Sole	2021-05-14
2020-12-31	$1,735,045	96,445	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.